fullerene c60 has been researched along with pentoxifylline in 1 studies
Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
---|---|---|---|---|---|
3,806 | 5 | 2,170 | 4,437 | 657 | 943 |
Protein | Taxonomy | fullerene c60 (IC50) | pentoxifylline (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 6.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CT; Huang, SH; Huang, ST; Lee, CM; Lin, CM; Lin, HW; Tsai, HP; Wu, JY | 1 |
1 other study(ies) available for fullerene c60 and pentoxifylline
Article | Year |
---|---|
C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide.
Topics: Amyloid beta-Peptides; Animals; Autophagy; Cell Line; Cell Survival; Fullerenes; Membrane Potential, Mitochondrial; Mice; Microscopy, Electron; Nanoparticles; Pentoxifylline; Reactive Oxygen Species | 2011 |